Continuous Glucose Monitoring for Prediabetes
(G3 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The objective of this project is to develop a behavioral intervention that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and educational video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with pre-diabetes. The goal is to prevent transition to type 2 diabetes (T2D).
Who Is on the Research Team?
David S Black, PhD MPH
Principal Investigator
University of Southern California Keck School of Medicine
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Masked CGM Phase
Participants wear CGM devices with glucose data masked for 10 days
Unmasked CGM Phase
Participants wear CGM devices with glucose data unmasked and receive daily health education videos
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Continuous Glucose Monitoring (CGM)
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants wear a CGM on the back of the arm. During Phase A, glucose values are not visible to participants. During Phase B, glucose values are visible via the phone app.
Find a Clinic Near You
Who Is Running the Clinical Trial?
David S Black, PhD
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.